Page last updated: 2024-11-06

prednisolone and Leukemia, Lymphocytic, Chronic, T Cell

prednisolone has been researched along with Leukemia, Lymphocytic, Chronic, T Cell in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Islam, A1
Majer, R1
Cumber, P1
Poynton, C1

Other Studies

1 other study available for prednisolone and Leukemia, Lymphocytic, Chronic, T Cell

ArticleYear
Chlorambucil and prednisolone therapy in a patient with T-cell chronic lymphocytic leukaemia.
    Clinical and laboratory haematology, 1996, Volume: 18, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Immunophenotypin

1996